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Abstract
Background: Epidemiological studies suggest that people who consume more than one portion of cruciferous vegetables
per week are at lower risk of both the incidence of prostate cancer and of developing aggressive prostate cancer but there
is little understanding of the underlying mechanisms. In this study, we quantify and interpret changes in global gene
expression patterns in the human prostate gland before, during and after a 12 month broccoli-rich diet.
Methods and Findings: Volunteers were randomly assigned to either a broccoli-rich or a pea-rich diet. After six months
there were no differences in gene expression between glutathione S-transferase mu 1 (GSTM1) positive and null individuals
on the pea-rich diet but significant differences between GSTM1 genotypes on the broccoli-rich diet, associated with
transforming growth factor beta 1 (TGFb1) and epidermal growth factor (EGF) signalling pathways. Comparison of biopsies
obtained pre and post intervention revealed more changes in gene expression occurred in individuals on a broccoli-rich diet
than in those on a pea-rich diet. While there were changes in androgen signalling, regardless of diet, men on the broccoli
diet had additional changes to mRNA processing, and TGFb1, EGF and insulin signalling. We also provide evidence that
sulforaphane (the isothiocyanate derived from 4-methylsuphinylbutyl glucosinolate that accumulates in broccoli) chemically
interacts with TGFb1, EGF and insulin peptides to form thioureas, and enhances TGFb1/Smad-mediated transcription.
Conclusions: These findings suggest that consuming broccoli interacts with GSTM1 genotype to result in complex changes
to signalling pathways associated with inflammation and carcinogenesis in the prostate. We propose that these changes
may be mediated through the chemical interaction of isothiocyanates with signalling peptides in the plasma. This study
provides, for the first time, experimental evidence obtained in humans to support observational studies that diets rich in
cruciferous vegetables may reduce the risk of prostate cancer and other chronic disease.
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Introduction
Prostate cancer is the most frequently diagnosed non-cutaneous
cancer within the male population of western countries [1].
Epidemiological studies have suggested that diets rich in
cruciferous vegetables, such as broccoli, may reduce the risk of
prostate cancer [2], in addition to cancers at other sites [3–9] and
myocardial infarction [10]. Some studies have specifically
demonstrated that consuming one or more portions of broccoli
per week can reduce the incidence of prostate cancer [11], and
also the progression from localized to aggressive forms of prostate
cancer [12]. The reduction in risk may be modulated by
glutathione S-transferase mu 1 (GSTM1) genotype, with individ-
uals who possess at least one GSTM1 allele (i.e. approximately
50% of the population) gaining more benefit than those who have
a homozygous deletion of GSTM1 [11]. Our study investigates the
mechanistic basis to the protective effect of broccoli and the
interaction with GSTM1 genotype.
Broccoli accumulates 4-methylsulphinylbutyl and 3-methylsul-
phinylpropyl glucosinolates in its florets, which are converted to
the isothiocyanates (ITCs) sulforaphane (SF) and iberin (IB),
respectively, either by plant thioglucosidases (‘myrosinases’)
following tissue damage or, if the myrosinases have been
denatured by cooking or blanching prior to freezing, by microbial
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have the pungent flavour qualities associated with other dietary
ITCs, such as those from mustards, rockets and watercress. SF and
IB are passively absorbed by enterocytes, conjugated with
glutathione and transported into the systemic circulation to be
metabolized via the mercapturic acid pathway and excreted
predominantly as N-acetylcysteine conjugates in the urine [14].
We previously demonstrated that following broccoli consumption,
45% of SF in the plasma occurs as free SF, as opposed to thiol
conjugates, and that the peak concentration of SF and its thiol
conjugates is less than 2 mM, falling to low (nM) levels within a few
hours [14]. It was also shown that GSTM1 null individuals excrete
a higher proportion of SF via mercapturic acid metabolism than
GSTM1 positive individuals, and it was speculated that the
remaining SF may be metabolized via an unknown pathway, and
that this may account for the anticarcinogenic activity of broccoli.
Cell and animal studies have shown that SF is a potent inducer
of phase 2 enzyme gene transcription, and, at higher concentra-
tions, of cell cycle arrest and apoptosis, all consistent with
anticarcinogenic activity [15]. However, these phenomena occur
when cultured cells are exposed to considerably higher levels of SF
(i.e. 10–100 mM for 24 h) than those found transiently in plasma
Figure 1. Metabolism of 4-methylsulphinylbutyl glucosinolate and sulforaphane. Upon entry into enterocytes sulforaphane (SF) is rapidly
conjugated to glutathione, exported into the systemic circulation and metabolized through the mercapturic acid pathway. Within the low
glutathione environment of the plasma the SF-glutathione conjugate may be cleaved, possibly mediated by GSTM1, leading to circulation of free SF
in the plasma. This free SF can modify plasma proteins including signalling molecules, such as TGFb, EGF and insulin.
doi:10.1371/journal.pone.0002568.g001
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these physiological concentrations, it is likely that any SF entering
cells would be immediately conjugated with glutathione due to the
relatively high intracellular glutathione concentration, with no
effect on, for example, the Keap1-Nrf2 complex [16,17].
Consistent with this hypothesis, there was no evidence for
induction of phase 2 gene transcription in the gastric mucosa
after an acute broccoli intervention [18].
In this study, we initially adopt an empirical approach in
humans to elucidate the mechanisms that underlie the beneficial
effects of a broccoli-rich diet, and explore the interaction with
GSTM1. We compare and interpret global gene expression profiles
in human prostate biopsy tissue before, during and after a 12
month broccoli-rich diet and a 12-month pea-rich diet. Subse-
quently, we provide a mechanistic explanation for how the
observed changes in gene expression may be induced by normal
dietary broccoli consumption.
Methods
Subjects and study design
Full details of the study protocol and the supporting CONSORT
checklist and flow diagram are available as supporting information
see Protocol S1, Checklist S1 and Figure S1. As stated in the
protocol, it was intended to recruit forty men with a previous
diagnosis of high-grade prostatic intraepithelial neoplasia (HGPIN),
the pre-invasive in situ stage of prostatic adenocarcinoma, into a
dietary intervention trial to study the effects of a diet rich in broccoli
and a diet rich in peas on prostate gene expression. However, due to
changesinclinical practice during the recruitment phase of the study
there was marked reduction in the numbers of men diagnosed with
HGPIN and it was not possible to recruit 40 men within the time
constraints of the research programme. Thus, twenty-two male
volunteers aged 57–70 years (Table 1) were recruited by a consultant
urologist at Norfolk and Norwich University Hospital NHS Trust.
Histological diagnosis was made by two consultant histopathologists,
who had a special interest inprostate pathology. Ethical approval for
the trial was obtained from the Norfolk Research Ethics Committee
(reference 05/Q0101/9, see Text S1). All participants gave written,
informedconsent.Volunteerswereexcludediftheywereundergoing
chemopreventive therapy, were receiving testosterone replacement
medication or 5 alpha reductase inhibitor, had active infection
requiring treatment, had a body mass index (BMI) ,18.5 or .35, or
were diabetic. Subjects were allocated into a 12-month, parallel
dietary intervention trial consisting of two dietary intervention
groups: (i) consuming 400 g broccoli per week or (ii) consuming
400 g peas per week, in addition to their normal diet. The trial was
conducted from April 2005–April 2007. Plasma prostate specific
antigen (PSA) levels were quantified prior to the intervention study
and after six and 12 months at the Norfolk and Norwich University
Hospital with the use of a total PSA immunoassay. Volunteers
avoided foods known to contain glucosinolates for 48 hours prior to
each biopsy appointment to avoid acute effects.
In addition to the transrectal ultrasound scan (TRUS)-guided
needle biopsies of the prostate obtained from the volunteers
immediately prior to the intervention study, and after six and
twelve months, 18 benign and 14 malignant transurethral
resection of the prostate (TURP) tissues were also obtained from
the Norfolk & Norwich University Hospital Partners in Cancer
Research Human Tissue Bank.
Dietary intervention
Vegetables were delivered to the volunteers on a monthly basis.
They were provided with a steamer and the volunteers were given
a demonstration by the diet cooks at the Institute of Food
Research of how to cook the vegetables. Portions of broccoli were
steamed for 4–5 minutes and portions of peas were steamed for 2–
3 minutes. Frozen peas (Birds Eye Garden Peas, http://www.
birdseye.co.uk/) were purchased from a local retail outlet. To
ensure consistency in glucosinolate content in frozen broccoli
provided to the volunteers, the broccoli required for the
intervention study was grown in one batch at an ADAS
experimental farm at Terrington, near King’s Lynn, UK
(http://www.adas.co.uk/) and processed by Christian Salvesen
(Bourne, Lincolnshire, UK, http://www.salvesen.co.uk/). It was
blanched at 90.1uC for 74 s, frozen at 230uC and packaged into
100 g portions, then stored at 218uC until steamed by the
volunteer. The broccoli was a high glucosinolate variety [19,20].
The levels, mean (SD), of 4-methylsulphinylbutyl and 3-methyl-
sulphinylpropyl glucosinolates (the precursors of SF and IB,
respectively) were 10.6 (0.38) and 3.6 (0.14) mmolesg
21 dry weight,
respectively, compared to 4.4 (0.12) and 0.6 (0.01) mmolesg
21 dry
weight in broccoli purchased from local retail outlets. Although the
level of glucosinolates were higher than standard broccoli,
Table 1. Volunteer characteristics and plasma PSA levels.
Age BMI GSTM1 PSA (ng/ml)
Pre-intervention 6-month 12-month
Broccoli intervention
68 29 null 4.6 5.4 5.3
68 27 null 3.1 3.2 2.9
64 26 null 9.4 3.5 2.9
63 31 null 6.5 7.9 7.2
66 28 null 0.9 1.3 0.9
Mean (sd) 4.9 (3.25) 4.3 (2.50) 3.84 (2.44)
57 27 positive 5.5 5.5 5.7
66 30 positive 13.6 16.8 13.4
69 27 positive 6.9 3.8 3.7
62 23 positive 2.2 2.2 1.9
59 29 positive 10.8 10.4 11.2
68 25 positive 9.7 12.5 7.2
64 32 positive 6.4 6.1 6.6
63 27 positive 7.9 9 10.8
Mean (sd) 7.9 (3.5) 8.3 (4.85) 7.56 (3.95)
Peas intervention
70 28 null 4.1 4.2 4.4
65 24 null 7.5 9.3 8.2
59 24 null 9.3 10.8 8
61 35 null 1.1 1.1 1.1
57 26 null 5.5 5.4 5.2
Mean (sd) 5.5 (3.15) 6.2 (3.92) 5.4 (2.92)
70 23 positive 8.9 5.2 N/A*
61 29 positive 2.3 2.2 2.5
57 30 positive 3.5 5.5 4.9
Mean (sd) 4.9 (3.52) 4.3 (1.82) 3.7 (1.70)
One of the 22 volunteers was diagnosed with prostatic adenocarcinoma at the
study baseline biopsy (pre-intervention) and was removed from the study.
*This volunteer developed prostatic adenocarcinoma six months into the
intervention and was removed from the study.
doi:10.1371/journal.pone.0002568.t001
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levels of SF and IB derived from the high glucosinolate broccoli
diet would be similar to or lower than those obtained from fresh
broccoli with functional myrosinase. Levels of indole glucosino-
lates were similar in both high glucosinolate and standard broccoli.
Compliance monitoring and dietary assessment
Volunteers completed weekly tick sheets during the 12-month
intervention period to identify when the portions of vegetables
were eaten. Every two weeks, volunteers were contacted by
telephone and asked about adherence to the diet. A seven-day
estimated food intake diet diary was completed by volunteers at
baseline and after six months using household measures as an
indication of portion size. Food intake from the diaries was
inputted into Diet Cruncher v1.6.1 (www.waydownsouthsoftware.
com/) and analyzed for differences in nutrient composition
between the two intervention groups at baseline and six months
after intervention.
Genotyping
Genomic DNA was extracted from whole blood or from tissue
samples using Qiagen QIAamp DNA minikit with RNase
treatment according to the manufacturer’s instructions (http://
www.qiagen.co.uk/). GSTM1 (NM_000561) genotype was deter-
mined using a real-time PCR procedure based on Covault and
colleagues, using gene specific primers and probe and quantified
relative to a two-copy gene control, a region in IVS10 of the breast
cancer 1, early onset (BRCA1, NM_007294) gene [21]. Primers
and probes were designed using Applied Biosystems Primer
Express (http://www.appliedbiosystems.com/) and are given with
PCR conditions in Table S1. Data were analyzed with Applied
Biosystems Absolute Quantification software.
RNA extraction and microarray hybridisation
Total RNA was isolated from the TURP tissue bank samples
and the TRUS-guided needle biopsies from the volunteers with
the use of QIAGENH RNeasy mini kits according to the
manufacturer’s instructions (http://www.qiagen.co.uk/). The
quantity of resulting RNA was measured using a spectrophotom-
eter (Beckman). The RNA quality was determined using the
Agilent 2100 Bioanalyzer (http://www.agilent.co.uk/). RNA
samples from TURP biopsies of benign and malignant prostates
and from TRUS-guided biopsies from both subject groups (peas
and broccoli) at baseline, and at six and 12 months after
intervention were hybridized onto Affymetrix Human U133 Plus
2.0 microarrays (http://www.affymetrix.com/) by the Nottingham
Arabidopsis Stock Centre (NASC, http://arabidopsis.info/).
Double-stranded cDNA synthesis and generation of biotin-labeled
cRNA were performed according to the manufacturer’s protocol
(Affymetrix, http://www.affymetrix.com/). The final cRNA was
checked for quality before fragmentation and hybridization onto
the arrays.
One of the 22 volunteers was diagnosed with prostatic
adenocarcinoma at the study baseline biopsy and was removed
from the study. Eleven samples from the baseline biopsies, two
samples from the six-month biopsies and three samples from the
12-month biopsies did not produce good quality RNA and/or
sufficient cRNA and were not hybridized. In addition, one
volunteer showed prostatic adenocarcinoma at the six-month
biopsy; subsequent samples were removed from the study.
Fluorescence intensity for each array was captured with a
GeneChipH Scanner 3000 7G. Affymetrix GeneChipH Operating
Software (GCOS) was used to quantitate each U133 Plus 2.0
array. Microarray data in this paper are compliant to the
minimum information about a microarray experiment (MIAME)
criteria and are deposited at Array Express (http://www.ebi.ac.
uk/microarray-as/aer; Accession Number E-MEXP-1243).
Microarray data analysis
Raw data files (CEL) were loaded into the DNA-Chip Analyzer
software (dChip, http://biosun1.harvard.edu/complab/dchip/,
build date September 2006) for normalization, generation of
expression values and statistical analysis. Following normalization
using the Invariant Set Normalization method, probe expression
levels were calculated using the PM-only model. To identify genes
that were changing between groups, different two-tailed P-value
thresholds were applied calculated by Welch modified two-sample
t-test in dChip. Paired or unpaired t-tests were performed as
appropriate. To correct for multiple testing, False Discovery Rate
(FDR) was estimated by permutation in dChip and the median of
100 permutations reported for each of the comparisons (1000
permutations on selected samples had little effect on FDR
calculations). Unsupervised clustering was performed on benign
and malignant samples using 1-Rank correlation as distance
metric on a gene list of 3697 probes. These probes satisfied two
criteria: first, that the coefficient of variation (CV) was between 0.5
and 1000; and secondly, that the percentage of Presence calls was
more than 20% across all TURP benign and malignant samples.
For the purpose of sample classification, 19 laser-capture
microdissected (LCD) epithelial cell microarrays (GEO Accession:
GDS1439, http://www.ncbi.nlm.nih.gov/geo/) and 32 TURP
benign and malignant microarrays were normalized together and
model-based expression was calculated as described above in
dChip. The LCD samples were derived from six benign prostate
tissue samples, five clinically localized primary prostatic adeno-
carcinoma samples, two replicates of the five primary cancer
samples after pooling, four metastatic prostatic adenocarcinoma
samples and two replicates of the four metastatic prostate cancer
samples after pooling [22]. Classification of the LCD epithelial cell
samples was then performed using linear discriminant analysis
(LDA) based on the TURP benign and malignant samples as
training samples. LDA was performed using 442 probes that had
higher than 100 units difference in signal intensity between TURP
benign and malignant samples and were significantly different at
P#0.01 by Welch modified two-sample t-test.To identify pathways
that are the most over-presented in the lists of differentially
expressed genes, functional analyses using MAPPFinder and
GenMAPP v2.1 were performed (http://www.genmapp.org/).
Incubation of peptides with isothiocyanates
Incubations of SF or IB with bovine insulin (P01308, Sigma-
Aldrich), recombinant human epidermal growth factor (EGF,
P01133, R&D Systems, http://www.rndsystems.com/) and re-
combinant human transforming growth factor beta 1 (TGFb1,
P01137, R&D Systems) were performed in sodium phosphate-
buffered saline solution (pH 7.4) or human blood plasma at 37uC
for 0.5–24 h. Plasma was pre-treated by ultrafiltration to remove
high molecular weight proteins (Microcon Ultracel YM-30 filter,
MWCO 30,000). Samples were either analyzed directly by LC-
MS/MS or by LC-MS/MS analysis of tryptic digests of gel
electrophoresis bands.
Direct LC-MS/MS analysis of peptides incubated with
isothiocyanates
The LC system used was a Shimadzu series 10AD VP
(Shimadzu, http://www.shimadzu.com/). The column was an
ACE 300 C18, 15062.1 mm (5 mm particle size) used at 40uC.
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0.1% formic acid in acetonitrile and the flow rate was 0.25 ml/
min. A linear gradient was used from 25% B to 35% B over 0 to
5 min, then a further gradient from 35% B to 99% B over 6 min
followed by 99% B for 4 min. The column was re-equilibrated for
a total of 3 min. The injection volume was between 5–20 ml. All
MS experiments were conducted on a 4000 QTRAP hybrid triple-
quadrupole linear ion trap mass spectrometer using Analyst
version 1.4.1 software (Applied Biosystems, http://www.applied-
biosystems.com/) equipped with a TurboIon source used in
positive ion electrospray mode. The probe capillary voltage was
optimized at 4200 V, desolvation temperature set to 400uC,
curtain gas, nebulizing and turbo spray gas were set to 40, 10 and
20, respectively (arbitrary values). Declustering potential was
ramped between 50–120 V. Nitrogen was used for collisionally
induced dissociation (CID). The peak-width was set on Q1 and Q3
at 1.0 Th (measured at half height) for all MS and MS/MS
experiments. Spectra were obtained over the range m/z 800–2000
with scan times of 1–2 sec. Operating in LIT mode Q0 trapping
was activated and dynamic fill time used, the scan rate was set to
250 Th/s for enhanced product ion (EPI) scans, excitation time
was 150 msec, excitation energy 25 V and entry barrier 4 V. For
EPI spectrum acquisition the precursor ions of interest for
conjugates of SF with insulin (m/z 1183.9 MH5
5+), EGF (m/z
1088.8, MH5
6+) and TGFb (m/z 1981.9, MH5
13+) were selected,
the collision energy was ramped between 30–120 V and spectra
were obtained over the range m/z 100–1500 with a scan time of
1.9 sec. MS
3 settings were identical to MS
2 except that the
collision energy was 50–80 V and declustering potential was 50–
80 V.
LC-MS/MS analysis of TGFb1 incubated with SF following
electrophoresis and tryptic digestion
1 mg aliquots of the TGFb1 protein, supplied with bovine serum
albumin as carrier, were incubated with either DMSO or
1.2 mmoles of SF for 30 minutes at 37uC and run onto denaturing
4–12% Bis-Tris NuPAGE gels (Invitrogen, http://www.invitro-
gen.com). Bands were excised and digested with trypsin (Promega,
http://www.promega.com/) after reduction with dithiothreitol
(DTT) and alklyation with iodoacetamide (Sigma-Aldrich, http://
www.sigmaaldrich.com/). Extracted peptides were lyophilized and
re-dissolved in 1% acetonitrile, 0.1% formic acid for analysis by
mass spectrometry. LC-MS/MS analysis was performed using a
LTQ mass spectrometer (Thermo Electron Corporation, http://
www.thermo.com/) and a nanoflow-HPLC system (Surveyor,
Thermo Electron). Peptides were applied to a precolumn (C18
pepmap100, LC Packings, http://www.lcpackings.com/) connect-
ed to a self-packed C18 8-cm analytical column (BioBasic resin
ThermoElectron; Picotip 75 mm id, 15 mm tip, New Objective,
http://www.newobjective.com/). Peptides were eluted by a
gradient of 2 to 30% acetonitrile in 0.1% formic acid over
40 min at a flow rate of approximately 250 nL min
21. Data-
dependent acquisition of MS/MS consisted of selection of the five
most abundant ions in each cycle: MS mass-to-charge ratio (m/z)
300 to 2000, minimum signal 1000, collision energy 25, 5 repeat
hits, 300 sec exclusion. In all cases the mass spectrometer was
operated in positive ion mode with a nano-spray source and a
capillary temperature of 200uC, no sheath gas was employed; the
source voltage and focusing voltages were optimized for the
transmission of angiotensin. Raw data were processed using
BioWorks 3.3 (Thermo Electron Corporation). Searches were
performed with Mascot (Matrix Science, http://www.
matrixscience.com/) against SPtrEMBL (4719335 sequences)
restricted by taxonomy to Homo sapiens (68982 sequences), oxidized
methionine and carbamidomethyl cysteine residues were allowed
as variable modifications as was putative SF. The error tolerance
of the parent ion was 61.2 Da and the fragment mass tolerance
was 60.6 Da, one missed cleavage was permitted. Error tolerant
searches in Mascot against TGFb were routinely performed and
extracted ion chromatograms and manual inspection of spectra
were prepared using Qual Browser and BioWorks 3.3 (Thermo
Electron Corporation).
Luciferase reporter gene assay
NIH 3T3 cells stably transfected with a CAGA12-luc plasmid,
which responds to Smad activation [23], were cultured in DMEM
supplemented with 10% fetal calf serum (FCS), 1% penicillin, 1%
streptomycin, 1% L-glutamine and 0.4 mg/ml geneticin. Cells
were seeded into complete growth medium in a six-well tissue
culture dish for 24 h, after which the medium was replaced with
low serum medium (0.5% FCS) containing one of three
treatments: (1) TGFb1 (to achieve a final concentration of
2n gm l
21) in PBS buffer, (2) TGFb1+10 mM DTT in PBS
buffer (3) TGFb1+2 mM SF in PBS buffer. To simulate SF
pharmacokinetics, all test samples were incubated at 37uC for
30 minutes prior to dialysis, performed in PBS buffer for 4 hours
using Slide-A-Lyzer Dialysis Cassettes MWCO 3.5K (PIERCE,
http://www.piercenet.com/). Dialysis reduced SF concentration
to 34 nM. As additional controls, cells were treated with PBS
without TGFb1 and PBS with SF (34 nM). The luciferase activity
was determined 16 h following treatment using the Luciferase
Reporter Gene assay (Roche Applied Science, http://www.roche.
com/) in a Perkin Elmer Wallac Victor 2 1420 multilabel counter
plate reader (http://las.perkinelmer.com/). Briefly, cells were
washed twice with PBS and lysed in cell lysis buffer supplied with
the assay. Chemiluminescence was immediately quantified
following the addition of luciferase assay substrate. Luciferase
values were normalized to protein concentration quantified using
the BCA assay (Sigma-Aldrich, http://www.sigmaaldrich.com/).
The experiment was repeated four times, with three replicates of
each treatment per experiment. Statistical analysis was performed
using 1-way ANOVA with the statistical software, R [24].
Results
Comparison of gene expression of benign and malignant
TURP tissue samples
We compared global gene expression profiles in surgically
resected benign and malignant prostate TURP tissue using RNA
extracted from heterogeneous tissue (such as we intended to use in
the intervention study). Unsupervised clustering distinguished
unambiguously the benign and malignant samples (data not
shown). Pathway analyses for genes that were significantly different
between the two groups were undertaken with the use of
GenMapp software, and identified pathways that are frequently
reported to be perturbed during carcinogenesis (Tables 2a and 3a).
To validate further our methods of data analysis and to determine
whether microarray data from gross heterogeneous tissue are
comparable to data generated from LCD epithelial cells, we
analyzed independent data sets of LCD epithelial cells (GEO
Accession: GDS1439) from benign, localized and metastatic
prostate cancer. We used our benign and malignant samples as
a training set for linear discriminant analyses (LDA) and the
independent data as test sets, and found that the LDA model
correctly distinguished the benign, localized and metastatic LCD
epithelial cell samples (Figure 2). Thus, this preliminary study
provides validation for our approach to the statistical analyses of
array data.
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PSA levels prior to the intervention were in similar range to that
previously reported for men of an equivalent age range diagnosed
with HGPIN [25]. There was no significant association with
GSTM1 genotype, and no consistent changes in PSA levels after
six or 12 months within either arm of the intervention study
(Table 1).
Differences in global gene expression between GSTM1
positive and null individuals
We initially genotyped the resected TURP tissue samples and
compared gene expression profiles between GSTM1 positive and
null genotypes within the benign and malignant samples. We found
few differences between genotypes, with similar high median false
discovery rates (Figure 3a, Table 3b). Likewise, we compared gene
expression profiles obtained from needle biopsies of the prostate
from GSTM1 positive and null men who had previously been
diagnosed with HGPIN and found few differences.
We then compared gene expression profiles between GSTM1
genotypes in needle biopsy tissue of twenty-one men who had been
recruited into the dietary intervention study. Eight of the men
within this study had been asked to consume 400 g of steamed
frozen peas per week, and the other thirteen were requested to
consume 400 g of steamed frozen broccoli per week, but otherwise
to consume their normal diet. Diet was assessed with seven-day
diet diaries prior to the intervention and after six months. No
significant differences were found in diet components, apart from
the consumption of broccoli and peas (Table 4). We found many
differences in the prostate gene expression between GSTM1
Table 2. Pathway analyses of prostate biopsy tissue.
Pathway
Genes changed/
Genes on MAPP
Adjusted
P-value*
a. Benign compared with malignant TURP tissue
Focal adhesion 57/187 ,0.001
TGFb receptor 47/151 0.002
Circadian exercise 20/48 0.006
Fatty acid metabolism 24/80 0.012
Prostaglandin synthesis regulation 14/31 0.026
Actin binding 53/213 0.028
GPCRs Class A rhodopsin-like 15/262 0.05
b. GSTM1 positives compared with GSTM1 nulls post six month
broccoli intervention
EGFR1 76/177 ,0.001
Adipogenesis 52/130 0.026
TGF-beta receptor 58/151 0.039
c. Paired samples pre and post 12 month dietary intervention
0–12 month peas
Androgen receptor 18/112 0.042
0–12 month broccoli **
mRNA processing 40/125 ,0.001
Androgen receptor 33/112 ,0.001
TGFb receptor 39/151 0.004
Insulin signalling 38/159 0.014
Delta-notch 24/ 85 0.019
Wnt signalling 28/109 0.02
EGFR1 40/177 0.02
IL-2 21/ 76 0.036
EGFR, epidermal growth factor receptor; GPCRs, G-protein coupled receptors; IL-
2, interleukin 2; TGFb, transforming growth factor beta; TURP, transurethral
resection of the prostate; Wnt, wingless-type MMTV integration site. Pathways in
GenMAPP that are enriched in the gene lists that differentiate groups are shown.
Only pathways with adjusted P values #0.05 are shown. Also, the number of
genes changing between groups that belong to these pathways is shown
alongside the total number of genes that constitute the pathway. Pathway
analysis was performed on gene lists generated in dChip that were statistically
significant (P#0.05, Welch modified two-sample paired or unpaired t-test)
between the two groups. No fold cutoff was used. For details on gene lists see
Table 3.
*P-values were calculated in GenMAPP using a non-parametric statistic based on
2000 permutations of the data and further adjusted for multiple testing by
Westfall-Young adjustment.
**GSTM1 positive volunteers, n=4.
doi:10.1371/journal.pone.0002568.t002
Table 3. Differentially expressed probes in prostate tissue.
Fold change P,0.05* P,0.005* P,0.0005*
(a) Differences between benign and malignant TURP tissue
Benign v Malignant .1.0 3810 (353) 683 (7) 124 (0)
.1.5 1081 (59) 400 (2) 104 (0)
.2.0 277 (7) 140 (0) 54 (0)
(b) Differences between GSTM1 positive and null genotypes
Benign (TURP) .1.0 661 (538) 19 (17) 0 (0)
.1.5 160 (186) 7 (14) 0 (0)
.2.0 50 (40) 1 (3) 0 (0)
Malignant (TURP) .1.0 686 (431) 8 (13) 0 (0)
.1.5 244 (152) 4 (8) 0 (0)
.2.0 44 (33) 1 (3) 0 (0)
Pre-intervention .1.0 730 (484) 26 (9) 0 (0)
.1.5 252 (79) 16 (3) 0 (0)
.2.0 43 (9) 8 (1) 0 (0)
6 month broccoli .1.0 7976 (351) 434 (4) 17 (0)
.1.5 2790 (91) 268 (2) 14 (0)
.2.0 316 (8) 31 (0) 1 (0)
6 month peas .1.0 220 (220) 6 (4) 0 (0)
.1.5 33 (41) 5 (3) 0 (0)
.2.0 5 (10) 1 (1) 0 (0)
(c) Differences between paired samples
0–12 months broccoli .1.0 2857 (96) 151 (0) 1 (0)
.1.5 1243 (12) 141 (0) 1 (0)
.2.0 213 (0) 62 (0) 1 (0)
0–12 months peas .1.0 1199 (42) 19 (0) 0 (0)
.1.5 495 (18) 19 (0) 0 (0)
.2.0 81 (1) 4 (0) 0 (0)
Probe numbers that have satisfied the comparison criteria of fold change and P-
value cutoffs are shown. Numbers in parentheses represent the median false
discovery rate calculated in dChip after 100 permutations of the samples.
*P-values were calculated in dChip by a Welch modified two-sample t-test.
n=18 for Benign, n=14 for Malignant; n=4 for GSTM1(+) Benign, n=14 for
GSTM1(2) Benign; n=5 for GSTM1(+) Malignant, n=9 for GSTM1(2)
Malignant; n=7 for GSTM1(+) Pre-intervention, n=3 for GSTM1(2) Pre-
intervention; n=6 for GSTM1(+) 6-month broccoli, n=5 for GSTM1(2) 6-month
broccoli; n=3 for GSTM1(+) 6-month pea and n=5 for GSTM1(2) 6-month pea
intervention.
**P-values were calculated in dChip by a Welch modified two-sample paired t-
test, n=4 for each of the diet interventions.
doi:10.1371/journal.pone.0002568.t003
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months, but few, if any, differences in gene expression between
GSTM1 positive and null men who had been on the pea diet
(Figure 3a, Table 3b). To investigate the potential consequences of
the differences in gene expression between GSTM1 genotypes
following the broccoli-rich diet, we analyzed these data via
GenMapp. Three pathways, EGF receptor, adipogenesis and
TGFb receptor, were identified in which genes occurred at a
higher frequency than they would by chance (Table 2b). The
relative expression of genes between the GSTM1 positive and null
men in the EGF receptor and TGFb receptor pathways are given
as supporting information (Table S2 and S3).
Changes in gene expression before and after the dietary
intervention
We used paired t-tests to identify genes that had changed in
expression between 0 and 6 months and 0 and 12 months in
biopsy samples from individuals within each arm of the
intervention to quantify changes in expression with time. Within
the broccoli arm, we restricted analyses to GSTM1 positive
individuals. We found after both 6 months and 12 months there
were more changes in expression within the broccoli-rich arm than
the pea-rich arm (Figure 3b, Table 3c). Pathway analyses with
genes that changed in expression between 0 and 12 months
identified changes only in the androgen receptor pathway in the
pea-rich arm, while in the broccoli-rich arm androgen receptor
pathway was identified, along with several other signalling
pathways, including insulin signalling, TGFb and EGF receptor
pathways (Table 2c, Table S4 and S5). Analyses with genes that
changed in expression between 0 and 6 months in the broccoli arm
also identified changes in TGFb receptor pathway (adjusted
P=0.001), insulin signalling (adjusted P=0.035) and EGF
receptor signalling (adjusted P=0.068).
Thus, evidence for the effect of broccoli consumption on
modulation of TGFb and EGF signalling has been obtained in two
independent analyses: Firstly, the comparison of gene expression
profiles of GSTM1 positive and null individuals who had
consumed the broccoli-rich diet for six months, and, secondly,
the paired analyses of gene expression profiles from biopsies
obtained at 0 and 12 months from GSTM1 positive individuals
who had consumed the broccoli-rich diet. It is important to note
that these analyses do not share any array data sets.
Chemical interactions between TGFb1, insulin and EGF
peptides and broccoli isothiocyanates
Having demonstrated that broccoli consumption modulates
several cell signalling pathways, we sought a mechanistic
explanation. Incubation of insulin, EGF and TGFb1 peptides
with the isothiocyanates SF or IB in PBS pH 7.4 at 37uC for a
period of 0.5 to 24 hours gave consistent evidence of the formation
of a covalently bound conjugate of the respective peptide and the
ITC. This was further investigated for physiological relevance by
performing the same incubations in human plasma depleted of
high MW proteins. LC-MS/MS analysis showed the appearance
of one or more additional LC-MS peaks when SF or IB were
incubated with the peptides. For example, in Figure 4 an extracted
ion chromatogram (m/z 1183.9, corresponding to insulin- SF
MH5
5+) shows the appearance of two insulin-SF conjugates
compared with the control incubation. MS
2 analysis of these
peaks (Figure 5) confirmed the presence of two diagnostic fragment
ions at m/z 235 and m/z 325 corresponding to the addition of SF
to the two N-terminal amino acids of insulin Gly-SF and Phe-SF.
Figure 2. LDA of an independent prostate microarray data set.
Linear discriminant analysis (LDA) using the benign (B) and malignant
(M) TURP prostate tissue for this study as training samples to classify the
laser-capture microdissected (LCD) epithelial prostate cell samples (GEO
Accession:GDS1439), consisting of benign (Be), primary cancer (PCa)
and metastatic cancer (MCa) samples. LDA was performed on a gene list
that distinguished the benign and malignant TURP samples as
described in Methods. Here, the first linear discriminant (LD1) is shown.
doi:10.1371/journal.pone.0002568.g002
Figure 3. Effect of dietary intervention on gene transcription. a, Number of probes that differ between GSTM1 positive and null genotypes
(P#0.005, Welch modified two-sample t-test) in TURP tissue from benign (Ben) and malignant (Mal) prostates, and TRUS-guided biopsy tissue from
volunteers at pre-intervention (Pre), post 6 months broccoli-rich diet (Broc) and post 6 months pea-rich diet (Peas). b, Number of probes that differ
between pre-intervention TRUS-guided biopsy samples and after 6 months broccoli (6B)-, 6 month pea (6P)-, 12 month broccoli (12B)- and 12 month
pea (12 P)-rich diets (P#0.005, Welch modified two-sample paired t-test). Shading correspond to different fold cutoffs applied. See Table 2 for full
details of probe numbers, P-values and median false discovery rates.
doi:10.1371/journal.pone.0002568.g003
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Phe-IB (m/z 311) from the incubation (data not shown).
Comparable evidence was obtained for the formation of EGF
conjugates with SF in human plasma corresponding to the
addition of SF to the N-terminal asparagines residue (m/z 309) of
EGF.
To provide additional information of modifications to TGFb1,
we adopted a complementary approach. 1 mg aliquots of the
protein were incubated with either DMSO or 1.2 mmoles of SF for
30 minutes at 37uC and separated by SDS-PAGE electrophoresis.
Bands were excised and digested with trypsin before analysis by
LC-MS/MS. TGFb1 was robustly identified in bands of 25 kDa
corresponding to the active dimer. The N-terminal peptide
ALDTNYCFSSTEK was identified from parent ion m/z 768.5
in both DMSO (control) and SF-treated samples (Figure 6). A
precursor ion m/z 877.2 was observed only in SF treated samples.
MS/MS analysis of both precursor ions revealed a strong series of
fragment peaks that were common to both (Figure 7) precursor
ions. These fragmentation patterns are consistent with the
unmodified y ion series for the peptide ALDTNYCFSSTEK
(including carbamidomethyl cysteine +57) and a b ion series
shifted by 217.460.8 Da in the SF-treated sample. These results
strongly support an N-terminal modification to TGFb1 by SF.
Addition of SF would result in a mass addition of 177, as observed
with LC-MS analyses of intact TGFb1, as described above. It is
highly likely that the addition of 217, as opposed to 177, is due to
subsequent reaction of the thiourea with iodoacetamide, added to
the reaction mixture to alkylate reduced disulphide linkages, to
result in a mixture of isomeric carbamimidoylsulfanylacetamides,
which undergo cyclisation and loss of NH3 to give the
corresponding iminothiazolidinones (Figure S2).
Enhancement of TGFb1 signalling after pre-incubation
with sulforaphane
As thiourea derivatives of proteins by isothiocyanates have been
shown to modify physicochemical and enzymatic properties
[26,27], we sought to assess whether SF modification of
extracellular signalling proteins had functional consequences. We
focussed on TGFb1 signalling due to its profound role in
maintaining tissue homoeostasis through controlling cell prolifer-
ation and behaviour [28,29]. TGFb1-induced Smad-mediated
transcription was quantified in NIH3T3 cells stably transfected
with a CAGA12-luc plasmid, in which luciferase activity can be
measured upon activation of Smad proteins [30]. Exposure of cells
to TGFb1 induced luciferase activity as expected. When cells were
exposed to TGFb1 that had been pre-incubated with physiolog-
ically appropriate concentrations of SF (2 mM) for 30 minutes
followed by dialysis, to simulate SF plasma pharmacokinetics [14],
there was an increase in Smad-mediated transcription compared
to exposure to TGFb1 alone (Figure 8). Exposure of cells to the
residual SF (34 nM) did not result in enhanced transcription
suggesting that SF induces Smad activation indirectly, consistent
with our previous observation that SF binds to the ligand itself. It is
also conceivable that SF may interact with the extracellular
domain of the receptor to alter downstream signalling.
Discussion
To our knowledge, this is the first dietary intervention study to
analyse global gene expression profiles within a target tissue before
and after a 12 month intervention, and to stratify gene expression
profiles by genotype. While we do not observe any consistent
changes in plasma PSA levels over the 12 month period of the
intervention, we were able to quantify extensive changes in gene
expression. We find little evidence to support potential mecha-
nisms derived from animal and cell models to explain the
observational data that consuming broccoli may reduce risk of
cancer, but considerable evidence for the perturbation of several
signalling pathways that are associated with carcinogenesis and
inflammation (Table 2b and c). It is possible that the net effect of
perturbation of these pathways may reduce the risk of cell
proliferation, and maintain cell and tissue homoeostasis. However,
whilst quantification of gene expression and pathway analyses
provides information concerning which pathways may be modified
by time or diet, it can provide little information about the precise
nature of how these pathways are perturbed. This requires further
Table 4. Dietary analysis of average daily intakes of nutrients.
Variable Baseline 6 months P-value*
Pea-rich diet (n=7)
Fat (g) 93.76 (32.97) 90.99 (25.83) 0.831
Protein (g) 87.50 (15.15) 95.77 (33.31) 0.526
CHO (g) 240.04 (79.85) 242.94 (72.97) 0.872
Energy (KJ) 9081.88 (2480.80) 9506.00 (2405.38) 0.738
Alcohol (g) 12.65 (9.87) 25.07 (35.42) 0.415
Cholesterol (mg) 353.57 (74.43) 345.29 (201.06) 0.930
Vitamin C (mg) 81.00 (66.05) 79.43 (62.58) 0.846
Vitamin E (mg) 8.24 (5.64) 7.15 (3.60) 0.395
Vitamin D (mg) 3.77 (3.25) 3.84 (1.76) 0.949
b-Carotene (mg) 1.94 (1.57) 3.22 (2.29) 0.184
Folate (mg) 261.00 (89.36) 332.86 (214.50) 0.489
Iron (mg) 11.73 (4.36) 13.32 (4.92) 0.555
Selenium (mg) 50.14 (13.01) 49.14 (23.08) 0.923
Peas (g) 8.57 (10.23) 57.41 (18.86) 0.001
Broccoli (g) 18.49 (30.89) 9.90 (13.61) 0.431
Estimated GSL (mmol) 9.36 (15.63) 5.01 (6.88) 0.431
Broccoli-rich diet (n=11)
Fat (g) 90.93 (29.27) 91.57 (33.70) 0.929
Protein (g) 96.99 (20.02) 96.97 (21.26) 0.996
CHO (g) 276.28 (76.03) 296.18 (72.99) 0.305
Energy (KJ) 9633.45 (2311.35) 9980.73 (2286.62) 0.488
Alcohol (g) 9.75 (7.20) 10.48 (9.70) 0.841
Cholesterol (mg) 337.27 (168.29) 298.46 (123.99) 0.211
Vitamin C (mg) 262.55 (175.83) 303.00 (188.52) 0.590
Vitamin E (mg) 11.31 (5.73) 11.14 (4.82) 0.924
Vitamin D (mg) 5.22 (3.17) 3.65 (1.08) 0.076
Beta Carotene (mg) 4.07 (3.01) 3.63 (2.53) 0.667
Folate (mg) 477.82 (188.20) 491.36 (193.47) 0.762
Iron (mg) 14.29 (2.09) 14.09 (2.25) 0.916
Selenium (mg) 77.09 (29.89) 68.82 (26.22) 0.304
Peas (g) 4.16 (5.51) 7.60 (8.46) 0.227
Broccoli (g) 25.89 (24.49) 55.84 (7.71) 0.002
Estimated GSL mmol 13.10 (12.39) 79.30 (10.94) ,0.0001
Variables shown are given in mean (sd) units per day. GSL refers to the
glucosinolate precursors of sulforaphane and iberin (ie 4-methylsulphinylbutyl
and 3-methylsulphinylpropyl glucosinolate) respectively. Similar analysis
between GSTM1 positive and null individuals showed no difference in dietary
intakes after 6 months within either broccoli-rich or pea-rich intervention.
*P-values were calculated in Minitab using a paired t-test.
doi:10.1371/journal.pone.0002568.t004
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protein modifications such as phosphorylation, associated with
components of the signal transduction pathway and downstream
targets. Furthermore, the effect of pathway perturbation may
depend upon the precise cell type, with potentially differential
effects occurring in epithelial and stromal cells. Despite these
reservations, it is of considerable interest that broccoli intervention
is associated with perturbation of TGFb1, EGF and insulin
signalling, each of which has been associated with prostate
carcinogenesis [31–35], in addition to carcinogenesis at other sites
[28,36,37], and inflammation associated with myocardial infarc-
tion [38]. It is noteworthy that broccoli consumption was also
associated with alterations in mRNA processing, and this is being
further explored.
It is likely that the major bioactive products derived from
broccoli are the isothiocyanates, sulforaphane and iberin. These
have been shown to have a multitude of biological activities in cell
models consistent with anticarcinogenic activity [15]. However,
these studies largely involve exposing cells to concentrations of SF
and IB far in excess of those which occur transiently in the plasma
after broccoli consumption, and are mediated by the intracellular
activity of the ITCs by, for example, perturbing intracellular redox
status, depletion of glutathione and perturbation of the Keap1-
Nfr2 complex. We question whether these processes would occur
in vivo, as any of the ITCs entering cells would immediately be
inactivated through conjugation with glutathione that would be
present in relatively high concentration. Thus, we explored
whether the biological activity of ITCs may be mediated through
their chemical interaction with signalling peptides within the
extracellular environment of the plasma, which has a low
glutathione concentration. We demonstrated that ITCs readily
form thioureas with signalling proteins in the plasma through
Figure 4. LC-MS of insulin incubated with and without SF in human plasma. Extracted ion LC-MS chromatograms (m/z 1183.6–1184.1) of
insulin-SF MH5
5+ in (A) unmodified insulin (20 mg/ml) in human plasma control and (B) human plasma incubated with insulin (20 mg/ml) and 50 mM
SF for 4 h at 37uC, showing the appearance of two different insulin-SF conjugates at retention times of 6.46 and 7.08 min. The enhanced product ion
(EPI)-MS spectra of these two insulin-SF conjugates are shown in Figure 5.
doi:10.1371/journal.pone.0002568.g004
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ITCs chemically react with other plasma proteins and a global
analysis of plasma protein modifications by ITCs is warranted. It is
also possible that other types of chemical modification of plasma
proteins by ITCs may occur, such as covalent bonding through
cysteine and lysine residues [39,40].
Previous studies have shown that isothiocyanate-derived
thioureas modify the physicochemical and enzymatic properties
of the parental proteins [26,27]. Thus, it is possible that the
perturbation of signalling pathways in the prostate is mediated by
protein modifications that occur in the extracellular environment.
We provide further evidence for this hypothesis by demonstrating
that pre incubation of TGFb1 with a physiological appropriate
concentration of SF (2 mM for 30 minutes), followed by dialysis for
4 h to simulate SF pharmacokinetics, results in enhanced Smad-
mediated transcription. As TGFb1/Smad-mediated transcription
inhibits cell proliferation in non-transformed cells [31,41], the
enhancement of Smad-mediated transformation by SF would be
consistent with the anticarcinogenic activity of broccoli, in
addition to reduced risk of myocardial infarction [10,38]. In
certain circumstances, enhancement of TGFb signalling has been
associated with tumour progression within already initiated cells,
although the precise pathways by which this is mediated have not
been fully resolved [42]. To what extent a broccoli-rich diet may
influence these processes requires further studies. However, we
consider it likely that it is the net effect of changes in several
pathways, as opposed to just TGFb1, which may underlie the
observed reduction in both cancer and myocardial infarction
through broccoli/crucifer consumption.
A previous study has demonstrated that isothiocyanates can
inhibit EGF signalling, but without a mechanistic explanation
[43]. In the current study, we show that SF will bind to the EGF
ligand, and this may underlie our results and those reported
previously [43]. Moreover, chemical modification of signalling
Figure 5. Enhanced product ion (EPI)-MS spectra of the two insulin-SF conjugates. MS
2 product ion spectra of (A) 6.46 min and (B)
7.08 min retention time peaks from LC-MS analysis of human plasma incubated with bovine insulin and 50 mM SF for 4 h at 37uC. In (A) and (B) m/z
1183.9 corresponds to insulin-SF MH5
5+ and in (A) m/z 235.0 corresponds to Gly-SF, the N-terminal amino acid of insulin A chain and in (B) m/z 325.2
corresponds to Phe-SF, the N-terminal amino acid of insulin B chain.
doi:10.1371/journal.pone.0002568.g005
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receptor proteins, as has previously been shown for the TRPA1
receptor [39,40].
Perturbation of signalling pathways is additionally determined by
GSTM1 genotype. The interaction between diet and GSTM1 on
gene expression may partially explain the contradictory results from
those case control studies which lack dietary assessment and which
have or have not associated the GSTM1 null genotype with
enhanced risk of prostate cancer [44–47]. GSTM1 enzyme activity
catalyses both the formation and the cleavage of SF – glutathione
conjugates [48]. We suggest that following transport intothe plasma
from enterocytes, GSTM1 activity (originating either from hepatic
cell turnover [49] or leakage from peripheral lymphocytes [50])
catalyses the cleavage of the SF-glutathione conjugate within the
low glutathione environment of the plasma [51] to determine the
extent of free SF that is available for protein modification, as
discussed above, and which is not excreted via mercapturic acid
metabolism (Figure 1). Thus low levels of SF, as would be expected
from normal dietary consumption of broccoli, may lead to subtle
changes in cell signalling, which, over time, result in profound
changes in gene expression. In this manner, consuming one portion
of broccoli per week if one is GSTM1 positive, or more if one is
GSTM1 null [14], may contribute to a reduction in cancer risk.
In addition to the insight this study provides to the effect of
broccoli consumption on gene expression, we consider that our
study may have broader implications. First, we demonstrate that
routine prostate needle biopsies can be used for global gene
expression analyses in addition to histological assessment, and that
it is possible to monitor changes in expression with time. It is
notable that men within both dietary arms of the study had
significant changes in the androgen receptor pathway. It is possible
that these changes in androgen signalling are associated with aging
and independent of diets, or they may have been induced by a
common component of both the broccoli-rich and pea-rich diet.
To our knowledge there is no data on the rate of change on
androgen signalling in men of this age with HGPIN. This
observation suggests further study is warranted. Analysis of the
rate of change of gene expression of men diagnosed with either
HGPIN or localized prostate cancer through sequential biopsies
may provide reliable biomarkers to measure the likelihood of both
carcinogenesis and progression to aggressive cancer, and comple-
ment histological examination of needle biopsies and measure-
ment of plasma PSA levels. Secondly, stratification of global gene
expression profiles by genotype has been informative, and this
approach could be extended to other genes to dissect patterns of
gene expression in prostate or other tissues. Lastly, it is conceivable
that other dietary phytochemicals, such as polyphenolic deriva-
tives, could also chemically interact with signalling peptides in the
plasma, in a similar manner to the suggested mechanism of action
of isothiocyanates.
Figure 6. LC-MS of TGFb1 incubated with and without SF. Extracted ion chromatograms (MS) of precursor masses representing the
unmodified N-terminal peptide of TGFb1( m/z 768.5) and the modified N-terminal peptide (m/z 877.2) A of m/z 768.2–769.2 from DMSO treated
TGFb1, B of m/z 768.2–769.2 from SF treated TGFb1, C of m/z 876.7–877.7 DMSO treated TGFb1 and D of m/z 876.7–877.7 SF treated TGFb1.
doi:10.1371/journal.pone.0002568.g006
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mechanistic basis for the reduction in risk of prostate cancer
through broccoli consumption, as suggested by epidemiological
studies. Further studies with larger cohorts, combined with the
assessment of clinical endpoints, are warranted.
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Figure 7. N-terminal modification of TGFb1 by SF. MS/MS spectra of m/z 768.7 representing the unmodified N-terminal peptide of TGFb1a t
retention time 23.43 min (A) and m/z 877.2 representing a modified form of TGFb1 seen only in SF treated samples at retention time 30.85 minutes
(B). Note that the y ion series remains the same while the b ion series shifts (D) indicating an N-terminal modification of mass 21760.8 Da. Figure S2
provides an explanation of the mass addition of 217, as opposed to 177.
doi:10.1371/journal.pone.0002568.g007
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